600993 马应龙
交易中 09-16 10:54:16
资讯
新帖
简况
每周股票复盘：马应龙（600993）Q2净利增7.43%，股东户数增6.55%
证券之星 · 08-30
每周股票复盘：马应龙（600993）Q2净利增7.43%，股东户数增6.55%
马应龙（600993）2026年中报简析：营收净利润同比双双增长
证券之星 · 08-27
马应龙（600993）2026年中报简析：营收净利润同比双双增长
股市必读：马应龙新发布《马应龙2026年半年度报告摘要》
证券之星 · 08-27
股市必读：马应龙新发布《马应龙2026年半年度报告摘要》
图解马应龙中报：第二季度单季净利润同比增长7.43%
证券之星 · 08-25
图解马应龙中报：第二季度单季净利润同比增长7.43%
每周股票复盘：马应龙（600993）每股派现0.70元含税
证券之星 · 08-02
每周股票复盘：马应龙（600993）每股派现0.70元含税
马应龙（600993）披露2025年年度权益分派实施公告，7月28日股价上涨2.52%
证券之星 · 07-28
马应龙（600993）披露2025年年度权益分派实施公告，7月28日股价上涨2.52%
马应龙（600993）1.1万股限售股将于7月22日解禁，占总股本0%
证券之星 · 07-22
马应龙（600993）1.1万股限售股将于7月22日解禁，占总股本0%
靠“肛需”狂赚5.8亿，一年卖出2亿支：邪修马应龙，还能在舒适区呆多久？
蓝鲸财经 · 07-21
靠“肛需”狂赚5.8亿，一年卖出2亿支：邪修马应龙，还能在舒适区呆多久？
每周股票复盘：马应龙（600993）10,950股限售股7月22日上市
证券之星 · 07-19
每周股票复盘：马应龙（600993）10,950股限售股7月22日上市
马应龙获得发明专利授权：“一种具有淡化眼袋功效的眼贴膜及其制备方法”
证券之星 · 07-18
马应龙获得发明专利授权：“一种具有淡化眼袋功效的眼贴膜及其制备方法”
马应龙（600993）披露股改限售股上市流通公告，7月16日股价上涨0.41%
证券之星 · 07-16
马应龙（600993）披露股改限售股上市流通公告，7月16日股价上涨0.41%
每周股票复盘：马应龙（600993）两药品新入基药目录
证券之星 · 07-12
每周股票复盘：马应龙（600993）两药品新入基药目录
马应龙（600993）披露子公司获得药品注册证书公告，7月10日股价下跌2.31%
证券之星 · 07-10
马应龙（600993）披露子公司获得药品注册证书公告，7月10日股价下跌2.31%
马应龙最新公告：子公司盐酸氮䓬斯汀滴眼液获药品注册证书
证券之星 · 07-10
马应龙最新公告：子公司盐酸氮䓬斯汀滴眼液获药品注册证书
7月9日马应龙发生1笔大宗交易 成交金额532.8万元
证券之星 · 07-09
7月9日马应龙发生1笔大宗交易 成交金额532.8万元
马应龙（600993）披露公司药品新增进入《国家基本药物目录》公告，7月9日股价上涨2.28%
证券之星 · 07-09
马应龙（600993）披露公司药品新增进入《国家基本药物目录》公告，7月9日股价上涨2.28%
马应龙（600993）披露将参加湖北辖区上市公司2026年投资者集体接待日活动，7月02日股价上涨1.62%
证券之星 · 07-02
马应龙（600993）披露将参加湖北辖区上市公司2026年投资者集体接待日活动，7月02日股价上涨1.62%
当代年轻人的难言之隐，养活了“老字号”马应龙
蓝鲸财经 · 06-29
当代年轻人的难言之隐，养活了“老字号”马应龙
每周股票复盘：马应龙（600993）获聚乙二醇3350散药品注册证书
证券之星 · 06-28
每周股票复盘：马应龙（600993）获聚乙二醇3350散药品注册证书
马应龙（600993）披露获得聚乙二醇3350散药品注册证书公告，6月25日股价下跌3.13%
证券之星 · 06-25
马应龙（600993）披露获得聚乙二醇3350散药品注册证书公告，6月25日股价下跌3.13%
加载更多
公司概况
公司名称：
马应龙药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2004-05-17
主营业务：
马应龙药业集团股份有限公司的主营业务是医药工业、医药商业和医疗服务。公司的主要产品是马应龙麝香痔疮膏、麝香痔疮栓、马应龙八宝眼膏、龙珠软膏等。
发行价格：
16.11
{"stockData":{"symbol":"600993","market":"SH","secType":"STK","nameCN":"马应龙","latestPrice":22.21,"timestamp":1789527256000,"preClose":22.33,"halted":0,"volume":1263600,"delay":0,"changeRate":-0.0054,"floatShares":430000000,"shares":430999999,"eps":1.394,"marketStatus":"交易中","change":-0.12,"latestTime":"09-16 10:54:16","open":22.4,"high":22.4,"low":22.12,"amount":28059400,"amplitude":0.0125,"askPrice":22.23,"askSize":26,"bidPrice":22.21,"bidSize":7,"shortable":0,"etf":0,"ttmEps":1.394,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1789529400000},"marketStatusCode":2,"adr":0,"adjPreClose":22.33,"symbolType":"stock","openAndCloseTimeList":[[1789522200000,1789529400000],[1789534800000,1789542000000]],"highLimit":24.56,"lowLimit":20.1,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":431053891,"isCdr":false,"pbRate":2.17,"roa":"--","peRate":15.932568,"roe":"7.95%","epsLYR":1.35,"committee":-0.06383,"marketValue":9574000000,"turnoverRate":0.0029,"status":1,"floatMarketCap":9557000000},"requestUrl":"/m/hq/s/600993","defaultTab":"news","newsList":[{"id":"2663930045","title":"每周股票复盘：马应龙（600993）Q2净利增7.43%，股东户数增6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663930045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663930045?lang=zh_cn&edition=full","pubTime":"2026-08-30 09:56","pubTimestamp":1788054970,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，马应龙报收于23.39元，较上周的23.01元上涨1.65%。本周，马应龙8月26日盘中最高价报23.99元。股本股东变化股东户数变动截至2026年6月30日，马应龙股东户数为4.41万户，较3月31日增加2710户，增幅6.55%。业绩披露要点财务报告马应龙2026年中报显示，上半年主营收入20.12亿元，同比上升3.22%；归母净利润3.63亿元，同比上升5.65%；扣非净利润3.42亿元，同比上升6.45%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","600993","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740623","title":"马应龙（600993）2026年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740623?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:07","pubTimestamp":1787782066,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期马应龙发布2026年中报。根据财报显示，马应龙营收净利润同比双双增长。截至本报告期末，公司营业总收入20.12亿元，同比上升3.22%，归母净利润3.63亿元，同比上升5.65%。持有马应龙最多的基金为招商均衡优选混合A，目前规模为18.95亿元，最新净值0.8307，较上一交易日下跌0.05%。本文数据来源于马应龙2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741517","title":"股市必读：马应龙新发布《马应龙2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662741517?lang=zh_cn&edition=full","pubTime":"2026-08-27 03:35","pubTimestamp":1787772920,"startTime":"0","endTime":"0","summary":"公司公告汇总马应龙2026年半年度报告摘要截至2026年6月30日，公司总资产5,751,769,098.33元，较上年度末增长5.80%；归属于上市公司股东的净资产4,440,319,016.70元，较上年度末增长1.38%。马应龙第十一届董事会第二十六次会议决议公告2026年8月24日，公司以通讯方式召开第十一届董事会第二十六次会议，审议通过《2026年半年度报告及其摘要》及《关于聘任公司总经理的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700007826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0188","600993","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736624","title":"图解马应龙中报：第二季度单季净利润同比增长7.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662736624?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:51","pubTimestamp":1787655078,"startTime":"0","endTime":"0","summary":"证券之星消息，马应龙2026年中报显示，上半年度公司主营收入20.12亿元，同比上升3.22%；归母净利润3.63亿元，同比上升5.65%；扣非净利润3.42亿元，同比上升6.45%；其中2026年第二季度，公司单季度主营收入9.99亿元，同比上升1.99%；单季度归母净利润1.5亿元，同比上升7.43%；单季度扣非净利润1.39亿元，同比上升10.0%；负债率20.61%，投资收益947.4万元，财务费用-603.39万元，毛利率46.87%。财报数据概要请见下图:本文数据来源于马应龙2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500039846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656666319","title":"每周股票复盘：马应龙（600993）每股派现0.70元含税","url":"https://stock-news.laohu8.com/highlight/detail?id=2656666319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656666319?lang=zh_cn&edition=full","pubTime":"2026-08-02 03:19","pubTimestamp":1785611950,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，马应龙报收于25.01元，较上周的23.16元上涨7.99%。本周，马应龙7月31日盘中最高价报25.06元。马应龙当前最新总市值107.81亿元，在中药板块市值排名19/66，在两市A股市值排名1619/5202。本周关注点公司公告汇总：马应龙每股派发现金红利0.70元（含税），股权登记日为2026年8月4日。本次利润分配以公司总股本431,053,891股为基数，共派发现金红利301,737,723.70元。分红对象为截至股权登记日在中国结算上海分公司登记在册的全体股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200001063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","600993","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654988335","title":"马应龙（600993）披露2025年年度权益分派实施公告，7月28日股价上涨2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654988335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654988335?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:31","pubTimestamp":1785249074,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，马应龙报收于24.01元，较前一交易日上涨2.52%，最新总市值为103.5亿元。该股当日开盘23.35元，最高24.05元，最低23.22元，成交额达1.8亿元，换手率为1.76%。近日，马应龙药业集团股份有限公司发布2025年年度权益分派实施公告：每股派发现金红利0.70元（含税），股权登记日为2026年8月4日，除权（息）日与现金红利发放日均为2026年8月5日。分红对象为截至股权登记日在中国结算上海分公司登记在册的全体股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800039997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600993","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653784388","title":"马应龙（600993）1.1万股限售股将于7月22日解禁，占总股本0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653784388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653784388?lang=zh_cn&edition=full","pubTime":"2026-07-22 08:16","pubTimestamp":1784679409,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，马应龙于7月22日将有1.09万股限售股份解禁，为公司股权分置限售股份，占公司总股本0.0%。本次解禁后，公司还有73.59万股限售股份，占总股本0.17%。马应龙主营业务：医药工业、医疗服务和医药商业。本文数据来源于马应龙公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200012707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993","BK0028","BK0096","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653226078","title":"靠“肛需”狂赚5.8亿，一年卖出2亿支：邪修马应龙，还能在舒适区呆多久？","url":"https://stock-news.laohu8.com/highlight/detail?id=2653226078","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653226078?lang=zh_cn&edition=full","pubTime":"2026-07-21 13:56","pubTimestamp":1784613406,"startTime":"0","endTime":"0","summary":"它就是江湖人称“肛界一哥”的马应龙。01拿捏“隐秘刚需”垄断赛道轻松躺赢出乎很多人意外的是，如今稳坐“肛界一哥”宝座的马应龙，并非生来就锁定肛肠赛道。2025年，马应龙治痔类产品总营收达17.31亿元，占公司总营收的45%，是绝对的核心现金牛，撑起了品牌半壁江山。首当其冲的便是核心专利崩塌，这也是马应龙当下最致命的经营隐患。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1784517839355924692","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0096","BK0239","BK0188","BK0028","600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652847230","title":"每周股票复盘：马应龙（600993）10,950股限售股7月22日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2652847230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652847230?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:18","pubTimestamp":1784398692,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，马应龙报收于23.69元，较上周的23.25元上涨1.89%。公司股本总额未发生变化，此前已有多次限售股上市流通情况。马应龙药业集团股份有限公司发布股改限售股上市流通公告，本次上市流通股份数量为10,950股，上市流通日期为2026年7月22日。本次上市股份涉及江耀祖等5名自然人股东及武汉华汉投资管理有限公司，合计解除限售10,950股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0096","BK0239","BK0028","600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652252287","title":"马应龙获得发明专利授权：“一种具有淡化眼袋功效的眼贴膜及其制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2652252287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652252287?lang=zh_cn&edition=full","pubTime":"2026-07-18 03:22","pubTimestamp":1784316137,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示马应龙新获得一项发明专利授权，专利名为“一种具有淡化眼袋功效的眼贴膜及其制备方法”，专利申请号为CN202311673501.1，授权日为2026年7月17日。今年以来马应龙新获得专利授权7个，较去年同期减少了12.5%。通过天眼查大数据分析，马应龙药业集团股份有限公司共对外投资了31家企业，参与招投标项目16005次；财产线索方面有商标信息751条，专利信息230条，著作权信息64条；此外企业还拥有行政许可435个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071800001621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","600993","BK0096","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651428361","title":"马应龙（600993）披露股改限售股上市流通公告，7月16日股价上涨0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651428361","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651428361?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:25","pubTimestamp":1784211918,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，马应龙报收于24.48元，较前一交易日上涨0.41%，最新总市值为105.52亿元。近日，马应龙药业集团股份有限公司发布股改限售股上市流通公告，本次上市流通股份数量为10,950股，上市流通日期为2026年7月22日。本次上市股份涉及江耀祖等5名自然人股东及武汉华汉投资管理有限公司，合计解除限售10,950股。此前已有多次限售股上市流通，本次为后续正常安排。保荐机构认为相关股东已履行股改承诺，本次上市符合规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600040245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","600993","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650549661","title":"每周股票复盘：马应龙（600993）两药品新入基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650549661","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650549661?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:24","pubTimestamp":1783794253,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，马应龙报收于23.25元，较上周的22.87元上涨1.66%。本周，马应龙7月9日盘中最高价报24.24元。交易信息汇总7月9日马应龙发生1笔大宗交易，成交金额532.8万元。公司公告汇总马应龙两个药品新增纳入《国家基本药物目录》，分别为马应龙八宝眼膏和托法替布片（处方药），适用于眼部炎症及类风湿关节炎等疾病，有利于未来市场拓展，但对当前经营业绩暂无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993","BK0188","BK0096","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650352741","title":"马应龙（600993）披露子公司获得药品注册证书公告，7月10日股价下跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650352741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650352741?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:27","pubTimestamp":1783693635,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，马应龙报收于23.25元，较前一交易日下跌2.31%，最新总市值为100.22亿元。近日，马应龙药业集团股份有限公司披露公告，其子公司江西马应龙美康药业有限公司收到国家药品监督管理局核准签发的盐酸氮斯汀滴眼液《药品注册证书》，注册分类为化学药品4类，非处方药，上市许可持有人为江西马应龙美康药业有限公司，生产企业为浙江尖峰药业有限公司。截至目前，公司对该药品累计研发投入766.21万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993","BK0239","BK0188","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650837401","title":"马应龙最新公告：子公司盐酸氮䓬斯汀滴眼液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2650837401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650837401?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:38","pubTimestamp":1783672687,"startTime":"0","endTime":"0","summary":"马应龙(600993.SH)公告称，公司子公司江西马应龙美康药业收到国家药监局核准签发的盐酸氮䓬斯汀滴眼液《药品注册证书》。该药品适用于治疗过敏性结膜炎引起的眼痒症状，为化学药品4类非处方药。2025年该药品国内市场销售额达1.54亿元，公司累计研发投入766.21万元。此次获批有助于丰富公司眼科产品线，但药品生产销售受行业政策及市场竞争影响存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0096","BK0239","BK0028","600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650407549","title":"7月9日马应龙发生1笔大宗交易 成交金额532.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650407549","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650407549?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:24","pubTimestamp":1783589089,"startTime":"0","endTime":"0","summary":"证券之星消息，7月9日马应龙发生大宗交易，交易数据如下：大宗交易成交价格22.2元，相对当日收盘价折价6.72%，成交24万股，成交金额532.8万元，买方营业部为招商证券股份有限公司沈阳兴工街证券营业部，卖方营业部为中泰证券股份有限公司杭州湖墅南路证券营业部。近三个月该股共发生1笔大宗交易，合计成交2400.0手，折价成交1笔。截至2026年7月9日收盘，马应龙报收于23.8元，上涨2.28%，换手率2.26%，成交量9.74万手，成交额2.32亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900030812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993","BK0028","BK0239","BK0096","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650409489","title":"马应龙（600993）披露公司药品新增进入《国家基本药物目录》公告，7月9日股价上涨2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650409489","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650409489?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:18","pubTimestamp":1783588683,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，马应龙报收于23.8元，较前一交易日上涨2.28%，最新总市值为102.59亿元。该股当日开盘23.21元，最高24.24元，最低22.98元，成交额达2.32亿元，换手率为2.26%。近日，马应龙药业集团股份有限公司发布关于公司药品新增进入《国家基本药物目录》的公告。公告显示，2026年7月9日，国家卫生健康委员会等部门发布《国家基本药物目录》，马应龙有两个药品新增纳入目录，分别为马应龙八宝眼膏和托法替布片，无药品退出。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900030270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","600993","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648468622","title":"马应龙（600993）披露将参加湖北辖区上市公司2026年投资者集体接待日活动，7月02日股价上涨1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648468622","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648468622?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:57","pubTimestamp":1783004232,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，马应龙报收于22.6元，较前一交易日上涨1.62%，最新总市值为97.42亿元。近日，马应龙药业集团股份有限公司发布《关于参加湖北辖区上市公司2026年投资者集体接待日活动的公告》。公告显示，公司将于2026年7月9日14:00-17:00通过网络远程方式参加由湖北证监局指导，湖北省上市公司协会与深圳市全景网络有限公司联合举办的“湖北辖区上市公司2026年投资者集体接待日活动”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0096","600993","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327203","title":"当代年轻人的难言之隐，养活了“老字号”马应龙","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327203","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647327203?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:22","pubTimestamp":1782724955,"startTime":"0","endTime":"0","summary":"而这条赛道里最具代表性的企业，是马应龙。精准吃透年轻人从预防到治疗的全链条需求后，马应龙搭建起分层清晰的产品矩阵。其中，仅麝香痔疮膏一年销量就近2亿支，牢牢守住肛肠药品成熟市场，也在消费者心中形成“肛周不适优先选马应龙”的固有认知。他们不好意思说出口的小毛病，撑起了马应龙近40亿元的年营收。依托稳定的大众刚需，马应龙沉淀出充足且可持续的现金流。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1782291655084784604","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0028","BK0188","BK0096","BK0239","600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646315319","title":"每周股票复盘：马应龙（600993）获聚乙二醇3350散药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315319","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646315319?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:10","pubTimestamp":1782587421,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，马应龙报收于21.55元，较上周的22.58元下跌4.56%。本周，马应龙6月24日盘中最高价报23.48元。本周关注点公司公告汇总：马应龙获聚乙二醇3350散药品注册证书，用于缓解偶发性便秘。公司公告汇总马应龙药业集团股份有限公司收到国家药品监督管理局核准签发的聚乙二醇3350散《药品注册证书》，药品注册分类为化学药品3类，上市许可持有人和生产企业均为本公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0028","BK0188","600993"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646809016","title":"马应龙（600993）披露获得聚乙二醇3350散药品注册证书公告，6月25日股价下跌3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646809016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646809016?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:47","pubTimestamp":1782398831,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，马应龙报收于21.99元，较前一交易日下跌3.13%，最新总市值为94.79亿元。近日，马应龙药业集团股份有限公司披露《关于获得药品注册证书的公告》。公告显示，公司收到国家药品监督管理局核准签发的聚乙二醇3350散《药品注册证书》，药品注册分类为化学药品3类，上市许可持有人和生产企业均为本公司。该药品用于缓解偶发性便秘，截至目前公司累计研发投入238.62万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600993","BK0028","BK0096","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789527258339,"stockEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0433},{"period":"3month","weight":0.0054},{"period":"6month","weight":-0.105},{"period":"1year","weight":-0.1363},{"period":"ytd","weight":-0.1792}],"compareEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0593},{"period":"6month","weight":-0.0355},{"period":"1year","weight":0.001},{"period":"ytd","weight":-0.0263}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"马应龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44114人(较上一季度增加6.55%)","perCapita":"9754股","listingDate":"2004-05-17","address":"湖北省武汉市洪山区武昌南湖周家湾100号","registeredCapital":"43105万元","survey":" 马应龙药业集团股份有限公司的主营业务是医药工业、医药商业和医疗服务。公司的主要产品是马应龙麝香痔疮膏、麝香痔疮栓、马应龙八宝眼膏、龙珠软膏等。","listedPrice":16.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"马应龙(600993)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供马应龙(600993)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"马应龙,600993,马应龙股票,马应龙股票老虎,马应龙股票老虎国际,马应龙行情,马应龙股票行情,马应龙股价,马应龙股市,马应龙股票价格,马应龙股票交易,马应龙股票购买,马应龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"马应龙(600993)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供马应龙(600993)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}